ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MBI Med Biogene Inc

0.045
0.00 (0.00%)
20 Dec 2024 - Closed
Delayed by 15 minutes

Med Biogene Financial Summary

The current MBI market cap is 776.57k. The company's latest EPS is USD -0.0034 and P/E is -5.88.

Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -63k-54k-60k-63k-58k
Net Income -63k-54k-60k-63k-58k
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 13k82k11k3k2k
Total Liabilities 50k178k92k69k129k
Total Equity -37k-96k-81k-66k-127k

Cash Flow

Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -151k72k-145k-8k3k
Investing N/A N/A N/A N/A N/A
Financing 164k N/A 75k-3k N/A
Market Cap 776.57k
Price to Earnings Ratio -5.88
Price to Sales Ratio 0
Price to Cash Ratio 200
Price to Book Ratio -2.72
Dividend Yield -

Share Statistics

Shares Outstanding 17.26M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.02 (30.77%)

Company Info

Company Name Med Biogene Inc
Address 598 east kent avenue south, vancouver
vancouver, british columbia V5X 4V6
Website https://www.medbiogene.com/en/406/index.html
Industry in vitro,in vivo diagnostics (2835)

Your Recent History

Delayed Upgrade Clock